America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David Joyner replacing Karen Lynch. CVS also withdrew its 2024 profit ...

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company last year, after investors including activist Glenview Capital pressured ...

The struggling pharmacy chain said Friday that the change in leadership is effective immediately. Lynch had been CEO since early 2021. [Images: Brendan Smialowski/AFP via Getty Images, slonme ...

Oct. 18 (UPI) --CVS Health announced on Friday it has appointed David Joyner as its new CEO, replacing Karen Lynch. CVS said that as of Thursday, Joyner -- who had been vice president of CVS ...

CVS Health is set to announce Q3 earnings results. Analysts expect a profit of $1.46 per share on revenue of $92.69B.

With Karen Lynch out and David Joyner up at CVS Health, Wall Street analysts expressed mixed sentiments about the company’s decision to promote internally but haven’t changed their long-term ...

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year and the health-care giant struggling on several fronts. Company shares tumbled again Friday after CVS Health ...

CVS gives third-quarter outlook below Street estimates Activist Glenview Capital says CVS board needs 'evolution' CVS plans to remain as one company under Joyner, sources say Oct 18 (Reuters ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other most profitable value stocks to invest in. Value investing is essentially focused ...